• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下注射乌司奴单抗后在猪模型中的药代动力学。

Ustekinumab pharmacokinetics after subcutaneous administration in swine model.

机构信息

Polpharma Biologics SA, 80-172 Gdańsk, Poland.

Sub-Department of Pharmacology, Toxicology and Environmental Protection, Faculty of Veterinary Medicine, University of Life Sciences, 20-033 Lublin, Poland.

出版信息

J Vet Sci. 2021 Sep;22(5):e47. doi: 10.4142/jvs.2021.22.e47. Epub 2021 May 27.

DOI:10.4142/jvs.2021.22.e47
PMID:34423596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8460463/
Abstract

BACKGROUND

Due to multiple similarities in the structure and physiology of human and pig skin, the pig model is extremely useful for biological drug testing after subcutaneous administration. Knowledge of the differences between subcutaneous injection sites could have a significant impact on the absorption phase and pharmacokinetic profiles of biological drugs.

OBJECTIVES

This study aimed to analyze the impact of administration site on pharmacokinetics and selected biochemical and hematological parameters after a single subcutaneous administration of ustekinumab in pigs. Drug concentrations in blood plasma were analyzed by enzyme-linked immunosorbent assay. Pharmacokinetic analyses were performed based on raw data using Phoenix WinNonlin 8.1 software and ThothPro v 4.1.

METHODS

The study included 12 healthy, female, large white piglets. Each group received a single dose of ustekinumab given as a 1 mg/kg subcutaneous injection into the internal part of the inguinal fold or the external part of the inguinal fold.

RESULTS

The differences in absorption rate between the internal and external parts of the inguinal fold were not significant. However, the time of maximal concentration, clearance, area under the curve calculated between zero and mean residence time and mean residence time between groups were substantially different ( > 0.05). The relative bioavailability after administration of ustekinumab into the external part of the inguinal fold was 40.36% lower than after administration of ustekinumab into the internal part of the inguinal fold.

CONCLUSIONS

Healthy breeding pigs are a relevant model to study the pharmacokinetic profile of subcutaneously administered ustekinumab.

摘要

背景

由于人类和猪皮在结构和生理学上有许多相似之处,因此猪模型对于皮下给药后生物药物的生物测试非常有用。对皮下注射部位差异的了解可能会对生物药物的吸收阶段和药代动力学特征产生重大影响。

目的

本研究旨在分析单次皮下给予乌司奴单抗后,给药部位对猪药代动力学和选定生化及血液学参数的影响。通过酶联免疫吸附试验分析血浆中的药物浓度。基于原始数据,使用 Phoenix WinNonlin 8.1 软件和 ThothPro v 4.1 进行药代动力学分析。

方法

该研究纳入了 12 头健康、雌性大白猪。每组猪均接受单次 1 mg/kg 乌司奴单抗皮下注射,注射部位分别为腹股沟内褶的内部或外部。

结果

腹股沟内褶内部和外部的吸收速率差异不显著。然而,两组之间达峰时间、清除率、从 0 到平均驻留时间的曲线下面积和平均驻留时间差异显著(>0.05)。与腹股沟内褶内部给药相比,乌司奴单抗外部给药的相对生物利用度降低了 40.36%。

结论

健康繁殖猪是研究皮下给予乌司奴单抗药代动力学特征的相关模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d5/8460463/6307685a8395/jvs-22-e47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d5/8460463/6307685a8395/jvs-22-e47-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4d5/8460463/6307685a8395/jvs-22-e47-g001.jpg

相似文献

1
Ustekinumab pharmacokinetics after subcutaneous administration in swine model.皮下注射乌司奴单抗后在猪模型中的药代动力学。
J Vet Sci. 2021 Sep;22(5):e47. doi: 10.4142/jvs.2021.22.e47. Epub 2021 May 27.
2
Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studies.两项 1 期研究中中国和非中国健康男性受试者间皮下乌司奴单抗的药代动力学比较。
Clin Drug Investig. 2013 Apr;33(4):291-301. doi: 10.1007/s40261-013-0072-2.
3
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.利用真实世界数据指导银屑病乌司奴单抗给药策略:一项前瞻性药代动力学-药效学研究。
Clin Transl Sci. 2020 Mar;13(2):400-409. doi: 10.1111/cts.12725. Epub 2020 Jan 29.
4
Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in pigs.猪静脉注射和皮下注射加米霉素后的药代动力学。
Res Vet Sci. 2014 Feb;96(1):160-3. doi: 10.1016/j.rvsc.2013.11.012. Epub 2013 Dec 1.
5
Population Pharmacokinetics and Exposure-Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis.人群药代动力学和暴露-反应建模分析乌司奴单抗在中重度活动性溃疡性结肠炎成人患者中的应用。
J Clin Pharmacol. 2020 Jul;60(7):889-902. doi: 10.1002/jcph.1582. Epub 2020 Feb 5.
6
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.乌司奴单抗治疗克罗恩病患者的药代动力学和暴露-反应关系。
Gastroenterology. 2018 May;154(6):1660-1671. doi: 10.1053/j.gastro.2018.01.043. Epub 2018 Feb 1.
7
The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting.在临床实践环境中,优特克单抗治疗的银屑病患者的临床疗效、血清谷浓度与抗药物抗体之间的相关性。
Br J Dermatol. 2015 Sep;173(3):855-7. doi: 10.1111/bjd.13834. Epub 2015 Aug 2.
8
Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.皮下而非静脉注射乌司奴单抗诱导与相当的循环药物水平和早期临床反应相关:一项初步研究。
Aliment Pharmacol Ther. 2018 Aug;48(3):333-339. doi: 10.1111/apt.14834. Epub 2018 Jun 19.
9
Pharmacokinetics of dexamethasone after intravenous and intramuscular administration in pigs.地塞米松在猪体内静脉注射和肌肉注射的药代动力学。
Vet J. 2013 Oct;198(1):286-8. doi: 10.1016/j.tvjl.2013.06.015. Epub 2013 Jul 19.
10
Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep.羊静脉注射和皮下注射替米考星后的药代动力学和生物利用度。
J Vet Pharmacol Ther. 2021 Jan;44(1):79-85. doi: 10.1111/jvp.12901. Epub 2020 Aug 3.

引用本文的文献

1
Oral Microbial Dysbiosis Driven by Periodontitis Facilitates Oral Squamous Cell Carcinoma Progression.由牙周炎驱动的口腔微生物失调促进口腔鳞状细胞癌进展。
Cancers (Basel). 2025 Jun 28;17(13):2181. doi: 10.3390/cancers17132181.
2
Comparative pharmacokinetics of porcine and human anti-influenza hemagglutinin monoclonal antibodies in outbred pigs and minipigs.猪和小型猪中外源抗流感血凝素单克隆抗体的比较药代动力学。
Front Immunol. 2024 Oct 31;15:1471412. doi: 10.3389/fimmu.2024.1471412. eCollection 2024.

本文引用的文献

1
Specificities of the Skin Morphology in Juvenile Minipigs.幼年小型猪皮肤形态学的特异性
Toxicol Pathol. 2018 Oct;46(7):821-834. doi: 10.1177/0192623318804520. Epub 2018 Oct 22.
2
Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability.影响皮下注射胰岛素吸收的因素:对变异性的影响。
J Diabetes Res. 2018 Jul 4;2018:1205121. doi: 10.1155/2018/1205121. eCollection 2018.
3
Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
理解皮下给予后单克隆抗体的处置情况:使用最小生理基于药代动力学模型。
J Pharm Pharm Sci. 2018;21(1s):130s-148s. doi: 10.18433/jpps30028.
4
Pharmacokinetics of Monoclonal Antibodies.单克隆抗体的药代动力学。
CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):576-588. doi: 10.1002/psp4.12224. Epub 2017 Jul 29.
5
Red Blood Cell Distribution Width is a Reliable Marker of Inflammation in Plaque Psoriasis.红细胞分布宽度是斑块状银屑病炎症的可靠标志物。
Acta Dermatovenerol Croat. 2017 Apr;25(1):26-31.
6
Red cell distribution width (RDW) is associated with cardiovascular disease risk in Crohn's disease.红细胞分布宽度(RDW)与克罗恩病的心血管疾病风险相关。
Clin Res Hepatol Gastroenterol. 2017 Sep;41(4):490-492. doi: 10.1016/j.clinre.2017.03.003. Epub 2017 Apr 12.
7
The using of a piglets as a model for evaluating the dipyrone hematological effects.使用仔猪作为评价安乃近血液学效应的模型。
BMC Vet Res. 2016 Nov 25;12(1):263. doi: 10.1186/s12917-016-0891-5.
8
Pigs in Toxicology: Breed Differences in Metabolism and Background Findings.毒理学中的猪:代谢方面的品种差异及背景研究结果
Toxicol Pathol. 2016 Jun;44(4):575-90. doi: 10.1177/0192623316639389. Epub 2016 Apr 4.
9
Lymphatic Territories (Lymphosomes) in Swine: An Animal Model for Future Lymphatic Research.猪的淋巴区域(淋巴小体):未来淋巴研究的动物模型。
Plast Reconstr Surg. 2015 Aug;136(2):297-304. doi: 10.1097/PRS.0000000000001460.
10
Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis.司库奇尤单抗成功治疗一名接受血液透析的寻常型银屑病患者。
J Dermatol. 2016 Jan;43(1):92-4. doi: 10.1111/1346-8138.12989. Epub 2015 Jun 24.